Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioning

Animal models of Parkinson’s disease (PD) based on neurodegenerative neurotoxins are essential preclinical tools for studying the disorder. In mice, intracranial infusion of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB) induces a severe lesion of the nigrostriatal pathway, mimicking the advanced stage of PD, when dopaminergic (DA) cell loss in the substantia nigra pars compacta (SNc) exceeds 95%. In contrast, intrastriatal infusion of 6-OHDA produces a milder lesion, modeling earlier disease stages. This latter model is mainly used to investigate possible compensatory mechanisms that delay the onset of motor deficits before DA depletion becomes extensive. Here, we present results from a study using the MFB 6-OHDA mouse model, in which a subset of animals with over 95% DA cell loss in the SNc exhibited neither acute nor chronic toxin-induced symptoms. To exclude the possibility that the absence of a PD phenotype resulted from inconsistent dopaminergic lesioning, we conducted a detailed analysis of dopaminergic cells and fibers in both the nigrostriatal and mesolimbic systems. Comparable lesions were observed in both typical and atypical PD mice. This finding suggests the presence of compensatory mechanisms in the MFB model that thus far may have been overlooked, given that this model is generally assumed to produce stable and severe motor deficits. Notably, animals that fail to display a robust parkinsonian phenotype are often excluded early in experiments under the assumption of an incomplete SNc lesion, which may introduce significant bias in preclinical PD research. • A subset of mice with >95% dopaminergic cell loss in the SNc displayed no PD phenotype. • Typical and atypical PD mice exhibited comparable nigrostriatal and mesolimbic lesions. • Possible compensatory mechanisms may underlie the absence of PD symptoms in atypical mice. • Lack of behavioral symptoms does not necessarily indicate an unsuccessful lesion in PD mouse models.

Authors

Institutions

Publication Details

Journal
Brain Mechanisms
Published
2025-10-01
DOI
https://doi.org/10.1016/j.bramec.2025.202523
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioning

Mario Ries, Yasin Temel, Kristen Kozielski, David Dominguez-Paredes et al.
Brain Mechanisms
Parkinson's Disease Mechanisms and Treatments
article

Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioning

Mario Ries, Yasin Temel, Kristen Kozielski, David Dominguez-Paredes, Ali Jahanshahi
article en

Abstract

Animal models of Parkinson’s disease (PD) based on neurodegenerative neurotoxins are essential preclinical tools for studying the disorder. In mice, intracranial infusion of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB) induces a severe lesion of the nigrostriatal pathway, mimicking the advanced stage of PD, when dopaminergic (DA) cell loss in the substantia nigra pars compacta (SNc) exceeds 95%. In contrast, intrastriatal infusion of 6-OHDA produces a milder lesion, modeling earlier disease stages. This latter model is mainly used to investigate possible compensatory mechanisms that delay the onset of motor deficits before DA depletion becomes extensive. Here, we present results from a study using the MFB 6-OHDA mouse model, in which a subset of animals with over 95% DA cell loss in the SNc exhibited neither acute nor chronic toxin-induced symptoms. To exclude the possibility that the absence of a PD phenotype resulted from inconsistent dopaminergic lesioning, we conducted a detailed analysis of dopaminergic cells and fibers in both the nigrostriatal and mesolimbic systems. Comparable lesions were observed in both typical and atypical PD mice. This finding suggests the presence of compensatory mechanisms in the MFB model that thus far may have been overlooked, given that this model is generally assumed to produce stable and severe motor deficits. Notably, animals that fail to display a robust parkinsonian phenotype are often excluded early in experiments under the assumption of an incomplete SNc lesion, which may introduce significant bias in preclinical PD research. • A subset of mice with >95% dopaminergic cell loss in the SNc displayed no PD phenotype. • Typical and atypical PD mice exhibited comparable nigrostriatal and mesolimbic lesions. • Possible compensatory mechanisms may underlie the absence of PD symptoms in atypical mice. • Lack of behavioral symptoms does not necessarily indicate an unsuccessful lesion in PD mouse models.

Brain MechanismsVol. 148-150
Netherlands Institute for Neuroscience (NL), Royal Netherlands Academy of Arts and Sciences (NL), Utrecht University (NL), Maastricht University Medical Centre (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Technical University of Munich (DE)
Openalex Percentile: Top 57%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.